These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38548128)
1. Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression. Yang Y; Liu X; Yang D; Li L; Li S; Lu S; Li N Metabolism; 2024 Jun; 155():155905. PubMed ID: 38548128 [TBL] [Abstract][Full Text] [Related]
2. CD36 tango in cancer: signaling pathways and functions. Wang J; Li Y Theranostics; 2019; 9(17):4893-4908. PubMed ID: 31410189 [TBL] [Abstract][Full Text] [Related]
3. CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis. Glatz JFC; Nabben M; Luiken JJFP Curr Opin Lipidol; 2022 Apr; 33(2):103-111. PubMed ID: 35125400 [TBL] [Abstract][Full Text] [Related]
4. The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target. Feng WW; Zuppe HT; Kurokawa M Cells; 2023 Jun; 12(12):. PubMed ID: 37371076 [TBL] [Abstract][Full Text] [Related]
5. CD36 and Its Role in Regulating the Tumor Microenvironment. Liao X; Yan S; Li J; Jiang C; Huang S; Liu S; Zou X; Zhang G; Zou J; Liu Q Curr Oncol; 2022 Oct; 29(11):8133-8145. PubMed ID: 36354702 [TBL] [Abstract][Full Text] [Related]
6. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240 [TBL] [Abstract][Full Text] [Related]
7. The role of CD36 in cardiovascular disease. Shu H; Peng Y; Hang W; Nie J; Zhou N; Wang DW Cardiovasc Res; 2022 Jan; 118(1):115-129. PubMed ID: 33210138 [TBL] [Abstract][Full Text] [Related]
8. Intestinal CD36 and Other Key Proteins of Lipid Utilization: Role in Absorption and Gut Homeostasis. Cifarelli V; Abumrad NA Compr Physiol; 2018 Mar; 8(2):493-507. PubMed ID: 29687890 [TBL] [Abstract][Full Text] [Related]
9. CD36 as a double-edged sword in cancer. Jiang M; Karsenberg R; Bianchi F; van den Bogaart G Immunol Lett; 2024 Feb; 265():7-15. PubMed ID: 38122906 [TBL] [Abstract][Full Text] [Related]
10. CD36: an emerging therapeutic target for cancer and its molecular mechanisms. Ruan C; Meng Y; Song H J Cancer Res Clin Oncol; 2022 Jul; 148(7):1551-1558. PubMed ID: 35224665 [TBL] [Abstract][Full Text] [Related]
11. CD36 as a target for metabolic modulation therapy in cardiac disease. Glatz JFC; Wang F; Nabben M; Luiken JJFP Expert Opin Ther Targets; 2021 May; 25(5):393-400. PubMed ID: 34128755 [No Abstract] [Full Text] [Related]
12. CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease. Glatz JFC; Heather LC; Luiken JJFP Physiol Rev; 2024 Apr; 104(2):727-764. PubMed ID: 37882731 [TBL] [Abstract][Full Text] [Related]
13. Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization. Glatz JFC; Luiken JJFP J Lipid Res; 2018 Jul; 59(7):1084-1093. PubMed ID: 29627764 [TBL] [Abstract][Full Text] [Related]
14. CD36 and lipid metabolism in the evolution of atherosclerosis. Zhao L; Varghese Z; Moorhead JF; Chen Y; Ruan XZ Br Med Bull; 2018 Jun; 126(1):101-112. PubMed ID: 29534172 [TBL] [Abstract][Full Text] [Related]
15. CD36 favours fat sensing and transport to govern lipid metabolism. Li Y; Huang X; Yang G; Xu K; Yin Y; Brecchia G; Yin J Prog Lipid Res; 2022 Nov; 88():101193. PubMed ID: 36055468 [TBL] [Abstract][Full Text] [Related]
16. CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Yang X; Okamura DM; Lu X; Chen Y; Moorhead J; Varghese Z; Ruan XZ Nat Rev Nephrol; 2017 Dec; 13(12):769-781. PubMed ID: 28919632 [TBL] [Abstract][Full Text] [Related]
17. CD36: The Bridge between Lipids and Tumors. Zhou X; Su M; Lu J; Li D; Niu X; Wang Y Molecules; 2024 Jan; 29(2):. PubMed ID: 38276607 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Fatty Acid Translocase (FAT/CD36) Palmitoylation Enhances Hepatic Fatty Acid β-Oxidation by Increasing Its Localization to Mitochondria and Interaction with Long-Chain Acyl-CoA Synthetase 1. Zeng S; Wu F; Chen M; Li Y; You M; Zhang Y; Yang P; Wei L; Ruan XZ; Zhao L; Chen Y Antioxid Redox Signal; 2022 Jun; 36(16-18):1081-1100. PubMed ID: 35044230 [No Abstract] [Full Text] [Related]
19. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats. Aragón-Herrera A; Feijóo-Bandín S; Otero Santiago M; Barral L; Campos-Toimil M; Gil-Longo J; Costa Pereira TM; García-Caballero T; Rodríguez-Segade S; Rodríguez J; Tarazón E; Roselló-Lletí E; Portolés M; Gualillo O; González-Juanatey JR; Lago F Biochem Pharmacol; 2019 Dec; 170():113677. PubMed ID: 31647926 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice. Chen M; Bai M; Yi Y; Lu S; Luo J; Li P; Zhang H; Jiang H; Zhou H Toxicol Lett; 2022 Jun; 363():1-10. PubMed ID: 35589016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]